Journal
AESTHETIC SURGERY JOURNAL
Volume 41, Issue -, Pages S16-S24Publisher
OXFORD UNIV PRESS INC
DOI: 10.1093/asj/sjaa426
Keywords
-
Categories
Funding
- Allergan Aesthetics, an Abbvie Company (Irvine, CA, USA)
- Suneva Medical, Inc. (San Diego, CA, USA)
Ask authors/readers for more resources
Autologous fat grafting is widely accepted and routinely performed in breast augmentation and reconstruction, with small-volume grafting being more predictable than large-volume grafting. This article aims to review outcomes of large-volume and megavolume fat grafting in breast augmentation and reconstruction.
Autologous fat grafting in the setting of breast augmentation and reconstruction has become globally accepted and routinely performed. There is general consensus that small-volume grafting is reproducible and predictable; however, large-volume fat grafting (>100 mL) is less predictable and is not as commonly performed. The aim of this article was to review outcomes following large-volume and megavolume fat grafting in the setting of breast augmentation and reconstruction.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available